AVSF - Beacon Biosignals 2025, LLC is a venture capital fund based in Boston, Massachusetts. According to its most recent Form D, filed Nov 17, 2025, it has sold $614,000 of interests to 26 investors since its first sale in Nov 2025. The minimum investment it accepts from an outside investor is $10,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Michael Collins.
- Total raised
- $614,000Cumulative sales reported on Form D
- Investors
- 26
- First sale
- Nov 1, 2025
- Minimum investment
- $10,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Michael Collins
- Latest Form D
- Nov 17, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about AVSF - Beacon Biosignals 2025, LLC
What is the minimum investment for AVSF - Beacon Biosignals 2025, LLC?
According to its latest Form D, filed Nov 17, 2025, the minimum investment AVSF - Beacon Biosignals 2025, LLC accepts from an outside investor is $10,000.
Who can invest in AVSF - Beacon Biosignals 2025, LLC?
AVSF - Beacon Biosignals 2025, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has AVSF - Beacon Biosignals 2025, LLC raised?
AVSF - Beacon Biosignals 2025, LLC reports $614,000 sold from 26 investors on its Form D filed Nov 17, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is AVSF - Beacon Biosignals 2025, LLC based?
AVSF - Beacon Biosignals 2025, LLC is based in Boston, Massachusetts.
When did AVSF - Beacon Biosignals 2025, LLC launch?
AVSF - Beacon Biosignals 2025, LLC reports its first sale in Nov 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every venture capital fund
Raised more than 55% of the 540 venture capital funds based in Massachusetts, and more than 53% of all 15,160 that report sales.